Evidence map›Paper›PMID 38058735›Full record

ArticleArchives of medical science : AMS2023

The national, regional, and global impact of glaucoma as reported in the 2019 Global Burden of Disease Study.

Huifeng Wu, Yinjun Wang, Feidi Li, Zelong Liu, Feifei Shi

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huifeng WuDepartment of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang, China.
Yinjun WangDepartment of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang, China.
Feidi LiDepartment of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang, China.
Zelong LiuSocial Development Security Bureau of Daxie Development Zone, Ning Bo, China.
Feifei ShiDepartment of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We investigated the disability-adjusted life years (DALYs) of glaucoma. Methods: The estimated annual percentage change (EAPC) was measured to assess trends in the age-standardized DALY rate from 1990 to 2019. Results: The global age-standardized DALY rate of glaucoma decreased with an EAPC of -1.00. The age-standardized DALY rate decreased least in high-SDI regions. Eastern sub-Saharan Africa had highest age-standardized DALY rate in 2019. At the national level, Mali had the highest age-standardized DALY rate in 2019. Conclusions: Although the global burden of glaucoma has decreased, the burden remain high in regions with low SDI values and in sub-Saharan Africa.

Indexed as

DALYsepidemiologyestimated annual percentage changeglaucomaGlobal Burden of Disease

Identifiers

PMID38058735
PMCPMC10696984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.